These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32425365)

  • 1. Why should we use convalescent plasma for COVID-19?
    Franchini M
    Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of convalescent plasma for COVID-19 treatment. History and evidence].
    McAllister F; Mantegazza A; Garzón F; Rotbaum V; Remondino G; Vazquez Larsson M; Geffner J; Rabinovich GA; Bover L
    Medicina (B Aires); 2020; 80 Suppl 3():82-86. PubMed ID: 32658853
    [No Abstract]   [Full Text] [Related]  

  • 4. Convalescent plasma for covid-19.
    Estcourt LJ; Roberts DJ
    BMJ; 2020 Sep; 370():m3516. PubMed ID: 32933945
    [No Abstract]   [Full Text] [Related]  

  • 5. Convalescent plasma to treat COVID-19.
    Bloch EM
    Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
    J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 10. Convalescent plasma is ineffective for covid-19.
    Pathak EB
    BMJ; 2020 Oct; 371():m4072. PubMed ID: 33093025
    [No Abstract]   [Full Text] [Related]  

  • 11. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
    Prajapati S
    Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
    [No Abstract]   [Full Text] [Related]  

  • 12. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
    Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
    Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent fecal microbiota transplantation as a possible treatment for COVID-19.
    Apartsin K; Smirnova V
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):e113-e114. PubMed ID: 32917563
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 17. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors.
    Andersen KJ; Klassen SA; Larson KF; Ripoll JG; Senefeld JW; Clayburn AJ; Shepherd JRA; Tseng AS; Wiggins CC; Murphy BM; Ford SK; Johnson CP; Miller AD; Baker SE; Wright RS; Winters JL; Stubbs JR; Joyner MJ; van Buskirk CM
    Mayo Clin Proc; 2020 Nov; 95(11):2343-2349. PubMed ID: 33153626
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
    Tamburello A; Marando M
    Swiss Med Wkly; 2020 Apr; 150():w20264. PubMed ID: 32343358
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
    Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
    J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
    Fleming AB; Raabe V
    J Clin Virol; 2020 Jun; 127():104388. PubMed ID: 32361326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.